The interrelationship between acne and depression: a systematic review
Abstract
About 9% of people worldwide suffer from acne vulgaris, a common dermatological disorder, with significant psychological sequelae including depression. Understanding the interrelationship between acne and depression is essential for comprehensive patient management. The data supporting the link between depression and acne were compiled in this systematic review to observe the prevalence, mediating mechanisms, impact of acne scars, and effects of isotretinoin treatment on depressive outcomes. For research published between 2021 and 2026, a thorough search of the literature was conducted using PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar. Fourteen studies including nine cross-sectional, three case-control, one cohort, and one population-based study met the inclusion criteria. The Joanna Briggs Institute Critical (JBI) Appraisal Checklist was used to evaluate quality. The frequency of depression among acne sufferers varied from 8.65% to 45.2%. Depression and acne severity were shown to be significantly correlated (r≤0.838, p<0.01). In more than 38% of patients, acne scars were linked to sadness. Body image disorder, psychological rigidity, and social avoidance were among the psychological mediators that accounted for 84.1% of the impact. Biological pathways implicated inflammation (NF-κB, HMGB1, and NLRP3) and metabolic alterations. Isotretinoin treatment generally improved depressive symptoms, though transient increases occurred during the first month. Acne demonstrated a robust association with depression through psychosocial and biological mechanisms. Routine depression screening, early effective treatment, and multidisciplinary approaches are recommended for optimal patient outcomes.